Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Takeda
Takeda
Takeda reports data from Phase II narcolepsy type 1 therapy trial
Clinical Trials Arena
Thu, 07/27/23 - 10:16 am
Takeda
TAK-994
narcolepsy
clinical trials
J&J touts Rybrevant win in newly diagnosed lung cancer, with key Tagrisso head-to-head readout up next
Fierce Pharma
Mon, 07/17/23 - 07:04 pm
JNJ
Rybrevant
non-small cell lung cancer
Takeda
Tagrisso
Takeda withdraws FDA approval application for dengue vaccine
BioPharma Dive
Tue, 07/11/23 - 11:22 pm
Takeda
FDA
dengue
vaccines
Takeda adds another F-Star collab to constellation, this time for $1B in biobucks
Fierce Biotech
Wed, 07/5/23 - 07:06 pm
Takeda
F-star Therapeutics
bispecific antibodies
immuno-oncology
Takeda reports interim results from Phase III trial of cTTP therapy
Clinical Trials Arena
Mon, 06/26/23 - 09:45 am
Takeda
TAK-755
cogenital thrombocytopenic purpura
ADHD Medication Shortage Worsens, Vyvanse Supply Dwindles Amid Adderall Scarcity
Yahoo/Benzinga
Thu, 06/22/23 - 11:21 am
ADHD
Vyvanse
drug shortages
Takeda
Lilly, Takeda Face Class-Action Racketeering Lawsuit Over Diabetes Drug
BioSpace
Thu, 06/8/23 - 10:13 am
Eli Lilly
Takeda
legal
Actos
bladder cancer
diabetes
racketeering
Yuhan makes $325M cancer bet to challenge Boehringer, Takeda
Fierce Pharma
Wed, 05/31/23 - 06:59 pm
Yuhan
cancer
Boehringer Ingelheim
Takeda
HER2 inhbitor
non-small cell lung cancer
Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and more cut staff
BioSpace
Wed, 05/31/23 - 11:15 am
layoffs
Rain Oncology
Takeda
PTC Therapeutics
Affimed
Urovant Sciences
Roche
Novavax
Gossamer Bio
Bristol Myers Squibb
ADC Therapeutics
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
FDA grants priority review for Takeda and HUTCHMED’s fruquintinib NDA
Pharmaceutical Technology
Fri, 05/26/23 - 11:31 am
Takeda
Hutchmed
FDA
fruquintinib
colorectal cancer
Takeda puts $510M on the line to expand KSQ cancer collaboration
Fierce Biotech
Wed, 05/17/23 - 10:09 am
Takeda
KSQ Therapeutics
cancer
oncology
Big Pharma layoffs: BMS, Roche and Takeda axe hundreds of jobs
Medical Marketing and Media
Mon, 05/15/23 - 10:04 am
layoffs
Bristol Myers Squibb
Roche
Takeda
Gossamer Bio
Novavax
Takeda cuts 2 midstage GI assets including Crohn's hopeful in latest pipeline cleanup
Fierce Biotech
Thu, 05/11/23 - 11:02 am
Takeda
R&D
gene therapy
earnings
Crohn’s disease
Gout Disease Control Suffered After FDA-Driven Price Hike: Study
BioSpace
Thu, 05/11/23 - 10:01 am
FDA
gout
colchicine
drug pricing
Takeda
Colcrys
Takeda Cuts 180+ Jobs Amid Pipeline Shake-Up
BioSpace
Mon, 05/8/23 - 11:48 pm
Takeda
layoffs
Massachusetts
Takeda tries again with subcutaneous Entyvio
Pharmaphorum
Fri, 04/28/23 - 10:02 am
Takeda
Entyvio
ulcerative colitis
Takeda taps Innate for a new celiac approach
EP Vantage
Thu, 04/13/23 - 09:58 am
Takeda
celiac disease
Innate Pharma
antibody-drug conjugate
Takeda hit with another pay-for-delay lawsuit, this time on gout drug Colcrys
Fierce Pharma
Wed, 04/12/23 - 10:07 pm
Takeda
pay-for-delay
generics
gout
Colcrys
Layoffs loom as Takeda trims early-stage efforts in AAV gene therapy, rare hematology
Fierce Biotech
Fri, 04/7/23 - 01:45 pm
Takeda
R&D
gene therapy
hematology
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »